{'52WeekChange': -0.17032963,
 'SandP52WeekChange': None,
 'address1': '460 Totten Pond Road',
 'address2': 'Suite 530',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 4.78,
 'askSize': 800,
 'averageDailyVolume10Day': 639162,
 'averageVolume': 770285,
 'averageVolume10days': 639162,
 'beta': 1.487589,
 'beta3Year': None,
 'bid': 4.44,
 'bidSize': 900,
 'bookValue': 1.697,
 'category': None,
 'circulatingSupply': None,
 'city': 'Waltham',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 4.54,
 'dayLow': 4.36,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -2.48,
 'enterpriseToRevenue': None,
 'enterpriseValue': 109874464,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 5.491286,
 'fiftyTwoWeekHigh': 7.75,
 'fiftyTwoWeekLow': 2.88,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 35403986,
 'forwardEps': -0.96,
 'forwardPE': -4.6145835,
 'fromCurrency': None,
 'fullTimeEmployees': 49,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.04517,
 'heldPercentInstitutions': 0.82544,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/chiasmapharma.com',
 'longBusinessSummary': 'Chiasma, Inc., a clinical late-stage '
                        'biopharmaceutical company, focuses on developing oral '
                        'medications using transient permeability enhancer '
                        'technology platform for the treatment of rare and '
                        'serious chronic disease worldwide. The company '
                        'develops oral octreotide capsules for adult patients '
                        'under the MYCAPSSA name, which is in Phase III '
                        'clinical trials for the treatment of acromegaly, a '
                        "condition that results in the body's production of "
                        'excess growth hormone. Chiasma, Inc. was founded in '
                        '2001 and is headquartered in Needham, Massachusetts.',
 'longName': 'Chiasma, Inc.',
 'market': 'us_market',
 'marketCap': 187235264,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_136932688',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -42956000,
 'nextFiscalYearEnd': 1640908800,
 'open': 4.53,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.07,
 'phone': '617-928-5300',
 'previousClose': 4.53,
 'priceHint': 4,
 'priceToBook': 2.610489,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 4.54,
 'regularMarketDayLow': 4.36,
 'regularMarketOpen': 4.53,
 'regularMarketPreviousClose': 4.53,
 'regularMarketPrice': 4.53,
 'regularMarketVolume': 393319,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 42265300,
 'sharesPercentSharesOut': 0.0513,
 'sharesShort': 2169978,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1363092,
 'shortName': 'Chiasma, Inc.',
 'shortPercentOfFloat': 0.0598,
 'shortRatio': 2.35,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'CHMA',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.112,
 'twoHundredDayAverage': 4.926223,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'b8c565e6-ee3e-3921-9405-889ca1da2334',
 'volume': 393319,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.chiasmapharma.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '02451'}